Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Thousands, $ in Thousands
Sep. 30, 2020
Mar. 31, 2020
Current assets:    
Cash and cash equivalents $ 12,517 $ 6,440
Restricted cash 792 830
Accounts receivable, net of allowance for doubtful accounts of $1,399 and $1,247 as of September 30, 2020 and March 31, 2020, respectively 62,712 70,370
Manufacturing inventories 35,882 29,196
Service parts inventories 23,211 20,502
Other current assets 8,330 8,489
Total current assets 143,444 135,827
Property and equipment, net 9,655 9,046
Restricted cash 5,000 5,000
Right-of-use assets, net 10,597 12,689
Other long-term assets 4,585 3,433
Total assets 173,281 165,995
Current liabilities:    
Accounts payable 37,834 36,949
Deferred revenue 73,101 81,492
Long-term debt, current portion 1,388 7,321
Accrued compensation 17,878 14,957
Other accrued liabilities 14,750 17,535
Total current liabilities 144,951 158,254
Deferred revenue 33,249 37,443
Long-term debt, net of current portion 171,010 146,847
Operating lease liabilities 9,114 10,822
Other long-term liabilities 11,197 11,154
Total liabilities 369,521 364,520
Commitments and contingencies (Note 9)
Stockholders' deficit    
Preferred stock, 20,000 shares authorized; no shares issued as of September 30, 2020 and March 31, 2020, respectively 0 0
Common stock, $0.01 par value; 125,000 shares authorized; 40,740 shares issued and outstanding as of September 30, 2020 and 39,905 as of March 31, 2020, respectively 408 399
Additional paid-in capital 522,357 505,762
Accumulated deficit (718,492) (703,164)
Accumulated other comprehensive loss (513) (1,522)
Total stockholders’ deficit (196,240) (198,525)
Total liabilities and stockholders’ deficit $ 173,281 $ 165,995
Common Stock, Shares, Outstanding 40,740 39,905
Common Stock, Shares, Issued 40,740 39,905